Synopsis: Many issues have been highlighted in the Phase-3 trial of Bharat Biotech’s COVID-19 vaccines. Those issues could have been avoided after HPV vaccine trial controversy. Introduction In a previous case, Human papilloma virus (HPV) vaccine trial was carried out on nearly 23,500 girls in the 10-14 age group in Vadodara, Gujarat and Khammam without proper consent. Almost eight years later the Supreme Court of India criticized the government for its inability to… Continue reading Issues in the process of COVID Vaccine trial
Tag: vaccine_related_issues
Preparing workforce for COVID vaccination
Synopsis:India is near vaccine roll out, but it lacks trained healthcare workers for the job. Introduction The permission of two COVID-19 vaccinats for emergency use is nearing. There is now hope of an end to the pandemic. But for the administration of vaccination and treatment properly and skillfully, a trained and effective workforce is… Continue reading Preparing workforce for COVID vaccination
Pune hub to track vaccine chain across 41 key cities
News: A command and control centre has been set up at Airports Authority of India Cargo Logistics and Allied Services Company Limited(AAICLAS) to monitor the movement of COVID-19 vaccines. Facts: Source: The Hindu What will AAICLAS do? It will be the nodal body for coordinating air transportation of the vaccines across a network of 41… Continue reading Pune hub to track vaccine chain across 41 key cities
Rising vaccine hesitancy and its solution
Synopsis- As the country readies to implement its COVID-19 vaccination programme, vaccine hesitancy could be an issue that the government needs to address forthwith. Introduction- Prime-Minister hailed the approval of two made in India COVID-19 vaccines by the drug regulator and said India is on the threshold of beginning the largest vaccination programme in the world. However, the COVID-19 vaccination intent is decreasing due to increasing hesitancy. … Continue reading Rising vaccine hesitancy and its solution
India approves two COVID-19 vaccines for emergency use
News: Central Drugs and Standards Committee(CDSCO) has approved the COVID-19 vaccines COVISHIELD and COVAXIN for restricted use in emergency situations. Initially, the 3 crore medical personnel considered at the highest risk for COVID-19, would be given the vaccine for free. Facts: Source: The Hindu COVISHIELD: It is a vaccine developed by the Serum Institute of India… Continue reading India approves two COVID-19 vaccines for emergency use
Approval to Covaxin, and Covishield Vaccines: Concerns and way forward
This article has been developed based on the Indian Express article “Turning point”. Synopsis- The Drug Controller General of India (DCGI) approved two vaccines — the indigenously developed Covaxin, and Covishield. There are several concerns associated with the hasty approval of vaccines. About Vaccines COVISHIELD: This vaccine is incubated in the laboratories of Oxford University and… Continue reading Approval to Covaxin, and Covishield Vaccines: Concerns and way forward
Concerns of hasty approval to COVID-19 vaccine
Synopsis- Concerns regarding hasty approval granted to the COVID-19 vaccines despites the lack of adequate efficacy data. Background- The Drug Controller General of India (DCGI) approved the Subject Expert Committee’s recommendation for emergency use of Serum Institute of India’s Covishieldand Bharat Biotech’s Covaxin. Covishieldis the same vaccine as developed by Oxford- AstraZeneca, which has got emergency use approval in the… Continue reading Concerns of hasty approval to COVID-19 vaccine
Expert panel grants emergency use authorisation for Oxford vaccine
News: The subject expert committee of Central Drugs Standard Control Organization(CDSCO) has recommended COVID-19 vaccine, Covishield for emergency use authorisation. Facts: COVISHIELD: The Oxford vaccine “AZD1222” is being called Covishield in India. Serum Institute of India(SII) has entered into a manufacturing partnership with Oxford University and Pharma major AstraZeneca to produce this vaccine in India. Technology: Covishield… Continue reading Expert panel grants emergency use authorisation for Oxford vaccine
Health Ministry plans communication strategy
News: Union Health Ministry has released a communication strategy to support the Covid-19 vaccine rollout in India that seeks to disseminate accurate and transparent information by alleviating apprehensions and ensuring its acceptance. Facts: About the strategy: The key areas that will be addressed as part of interventions under the strategy are: Giving information on Covid-19 vaccines Addressing… Continue reading Health Ministry plans communication strategy
Government launches Indian SARS-CoV-2 Genomic Consortia(INSACOG) Group
News: Government of India has launched the Indian SARS-CoV-2 Genomic Consortia Group(INSACOG). Facts: INSACOG: It has been established to monitor the genomic variations in the SARS-CoV-2 on a regular basis through a multi-laboratory network. Composition: It comprises 10 labs (NIBMG Kolkata, ILS Bhubaneswar, NIV Pune, CCS Pune, CCMB Hyderabad, CDFD Hyderabad, InSTEM Bengaluru, NIMHANS Bengaluru, IGIB Delhi… Continue reading Government launches Indian SARS-CoV-2 Genomic Consortia(INSACOG) Group
